Becton Dickinson (BD) is deploying a new AI platform called Incada designed to integrate data from the company's patient monitoring systems and medication management devices. Bilal Muhsin, president of BD's connected care business, stated that the initiative aims to improve clinical workflows and reduce alarm fatigue by providing more actionable, predictive alerts to hospital staff. According to Muhsin, the company’s systems can now predict patient deterioration, such as the onset of hypotension 15 minutes in advance, with existing algorithms already clearing regulatory review.

Incada operates as a cloud-based software layer intended to aggregate high-frequency physiological waveforms and medication administration data. Muhsin emphasized that unlike electronic medical records (EMRs) which typically capture data snapshots every 15 minutes, Incada processes real-time information to track the exact timing and dosage of infused drugs alongside physiological responses. This rich data integration is expected to assist in automating drug titration and inventory management, effectively serving as a central hub for hospitals already using BD hardware.

Regarding the balance between technological utility and clinical burnout, the company aims to move away from traditional threshold-based alarms. By analyzing multiple parameters simultaneously, Incada identifies whether an alert signifies a genuine patient safety issue or an episodic event, such as a displaced sensor. BD intends to provide transparency by detailing the specific factors triggering each alert. The platform is being rolled out as a SaaS (software-as-a-service model, providing applications over the internet) solution designed to complement existing hospital infrastructure without requiring significant new capital investment for facilities already equipped with BD monitoring and dispensing technologies.

Becton Dickinson (BD) is deploying a new AI platform called Incada designed to integrate data from the company's patient monitoring systems and medication management devices. Bilal Muhsin, president of BD's connected care business, stated that the initiative aims to improve clinical workflows and reduce alarm fatigue by providing more actionable, predictive alerts to hospital staff. According to Muhsin, the company’s systems can now predict patient deterioration, such as the onset of hypotension 15 minutes in advance, with existing algorithms already clearing regulatory review.

Incada operates as a cloud-based software layer intended to aggregate high-frequency physiological waveforms and medication administration data. Muhsin emphasized that unlike electronic medical records (EMRs) which typically capture data snapshots every 15 minutes, Incada processes real-time information to track the exact timing and dosage of infused drugs alongside physiological responses. This rich data integration is expected to assist in automating drug titration and inventory management, effectively serving as a central hub for hospitals already using BD hardware.

Regarding the balance between technological utility and clinical burnout, the company aims to move away from traditional threshold-based alarms. By analyzing multiple parameters simultaneously, Incada identifies whether an alert signifies a genuine patient safety issue or an episodic event, such as a displaced sensor. BD intends to provide transparency by detailing the specific factors triggering each alert. The platform is being rolled out as a SaaS (software-as-a-service model, providing applications over the internet) solution designed to complement existing hospital infrastructure without requiring significant new capital investment for facilities already equipped with BD monitoring and dispensing technologies.